CIK 0001839439
PYCR PAYCOR HCM, INC.
Insider trading from SEC Form 4. Last filing Apr 15, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Signals
Open-market buys and sells at PAYCOR HCM, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 7Weak | Jeremy Rishel director sell | $52k 3,723 shares | -15% | - |
Transactions
The last 27 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 14, 2025 | Drury Armstrong director | DDisposition to issuer Common Stock | -11,864 | $22.50 | $267k | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Ryan Norman Bergstrom See Remarks | DDisposition to issuer Common Stock | -347,460 | $22.50 | $7.8M | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Adam Brooks Ante Chief Financial Officer | DDisposition to issuer Common Stock | -490,942 | $22.50 | $11M | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Whitney Marilinn Bouck director | DDisposition to issuer Common Stock | -32,571 | $22.50 | $733k | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Kathleen Ann Burke director | DDisposition to issuer Common Stock | -32,571 | $22.50 | $733k | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Adam Brooks Ante Chief Financial Officer | AGrant or award Common Stock | +91,614 | $0.00 | $0 | 91,614 | Apr 15, 2025 |
| Apr 14, 2025 | Ryan Norman Bergstrom See Remarks | AGrant or award Common Stock | +68,711 | $0.00 | $0 | 68,711 | Apr 15, 2025 |
| Apr 14, 2025 | Adam Brooks Ante Chief Financial Officer | DDisposition to issuer Common Stock | -91,614 | - | - | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Ryan Norman Bergstrom See Remarks | DDisposition to issuer Common Stock | -68,711 | - | - | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Adam Brooks Ante Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -173,611 | $0.00 | $0 | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Ryan Norman Bergstrom See Remarks | DDisposition to issuer Stock Option (Right to Buy)derivative | -85,160 | $0.00 | $0 | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Adam Brooks Ante Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -105,080 | $0.00 | $0 | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Ryan Norman Bergstrom See Remarks | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,054 | $0.00 | $0 | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Adam Brooks Ante Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -92,184 | $0.00 | $0 | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Ryan Norman Bergstrom See Remarks | DDisposition to issuer Stock Option (Right to Buy)derivative | -57,615 | $0.00 | $0 | 0 | Apr 15, 2025 |
| Apr 14, 2025 | Ryan Norman Bergstrom See Remarks | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,235 | $3.06 | $59k | 0 | Apr 15, 2025 |
| Apr 1, 2025 | Ryan Norman Bergstrom See Remarks | FTax withholding Common Stock | -8,065 | $22.47 | $181k | 347,460 | Apr 2, 2025 |
| Mar 7, 2025 | Adam Brooks Ante Chief Financial Officer | AGrant or award Common Stock | +336 | $15.59 | $5,238 | 497,474 | Apr 2, 2025 |
| Apr 1, 2025 | Adam Brooks Ante Chief Financial Officer | FTax withholding Common Stock | -6,538 | $22.47 | $147k | 490,936 | Apr 2, 2025 |
| Feb 4, 2025 | Alice L Geene See Remarks | FTax withholding Common Stock | -9,997 | $22.13 | $221k | 210,447 | Feb 6, 2025 |
| Jan 1, 2025 | Adam Brooks Ante Chief Financial Officer | FTax withholding Common Stock | -6,979 | $18.57 | $130k | 497,138 | Jan 3, 2025 |
| Jan 1, 2025 | Ryan Norman Bergstrom See Remarks | FTax withholding Common Stock | -4,651 | $18.57 | $86k | 355,525 | Jan 3, 2025 |
| Jan 1, 2025 | Alice L Geene See Remarks | FTax withholding Common Stock | -4,136 | $18.57 | $77k | 220,047 | Jan 3, 2025 |
| Jan 1, 2025 | Sarah Kathryn Haines Chief Accounting Officer | FTax withholding Common Stock | -683 | $18.57 | $13k | 46,974 | Jan 3, 2025 |
| Dec 31, 2024 | Alice L Geene See Remarks | AGrant or award Common Stock | +397 | $10.92 | $4,335 | 220,444 | Jan 3, 2025 |
| Oct 23, 2024 | Drury Armstrong director | AGrant or award Common Stock | +11,864 | $14.33 | $170k | 11,864 | Oct 24, 2024 |
| Oct 16, 2024 | Jeremy Rishel director | SOpen-market sale Common Stock10b5-1 | -3,723 | $14.02 | $52k | 21,218 | Oct 16, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Adam Brooks AnteChief Financial Officer
- Drury Armstrongdirector
- Ryan Norman BergstromSee Remarks
- Whitney Marilinn Bouckdirector
- Kathleen Ann Burkedirector
- Alice L GeeneSee Remarks
- Sarah Kathryn HainesChief Accounting Officer
- Jeremy Risheldirector, officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.